相似文献
1
Antisense ICAM-1 oligonucleotides block allograft rejection in rats.
Transplant Proc. 1997 Feb-Mar;29(1-2):1285. doi: 10.1016/s0041-1345(96)00638-0.
2
Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
Transplantation. 1998 Sep 27;66(6):699-707. doi: 10.1097/00007890-199809270-00003.
3
Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicity.
Transplantation. 2005 Feb 27;79(4):401-8. doi: 10.1097/01.tp.0000149505.53886.27.
4
Application of antisense oligodeoxynucleotides for organ transplantation.
Transplant Proc. 1998 Aug;30(5):2142-5. doi: 10.1016/s0041-1345(98)00567-3.
5
The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Transplantation. 1992 Feb;53(2):303-8. doi: 10.1097/00007890-199202010-00009.
6
Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
Transplant Proc. 1995 Feb;27(1):113.
7
8
Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB.
Transplant Proc. 1997 Feb-Mar;29(1-2):1253. doi: 10.1016/s0041-1345(96)00486-1.
9
Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats.
Transplant Proc. 1998 Dec;30(8):4337-9. doi: 10.1016/s0041-1345(98)01432-8.
10
Development of tolerance in a chronic rejection model.
Transplant Proc. 1998 Jun;30(4):1075-6. doi: 10.1016/s0041-1345(98)00158-4.
Zotero 插件